A number of research firms have changed their ratings and price targets for Insulet (NASDAQ: PODD): 5/13/2024 – Insulet had its price target lowered by analysts at Barclays PLC from $213.00 to $200.00. They now have an “equal weight” rating on the stock. 5/10/2024 – Insulet had its price target lowered by analysts at Raymond […]
Eaton Financial Holdings Company LLC bought a new stake in Insulet Co. (NASDAQ:PODD – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 20,845 shares of the medical instruments supplier’s stock, valued at approximately $4,523,000. Insulet […]
Founders Financial Alliance LLC cut its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 8.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,341 shares of the medical instruments supplier’s stock after selling 126 shares during the quarter. […]
Primecap Management Co. CA lessened its stake in Insulet Co. (NASDAQ:PODD – Free Report) by 5.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 643,478 shares of the medical instruments supplier’s stock after selling 39,720 shares during the period. Primecap Management Co. […]
Primecap Management Co. CA cut its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 5.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 643,478 shares of the medical instruments supplier’s stock after selling 39,720 shares during the […]